Answer:
THEIR INABILITY TO CROSS THE BLOOD-BRAIN BARRIER AT THERAPEUTIC LEVELS.
Step-by-step explanation:
Second-generation antihistamines (e.g., loratadine, terfenadine) lack the ability to pass through the blood-brain barrier at certain therapeutic levels.